Current Environment: Production

Medical Services

Programs & Services

Languages

  • English

Education

Medical School

Harvard Medical School

2001, Boston, MA

Internship

Medicine

Boston Children's Hospital

2002, Boston, MA

Residency

Pediatrics

Boston Combined Residency Program (BCRP)

2004, Boston, MA

Fellowship

Pediatric Hematology -Oncology

Boston Children's Hospital/Dana-Farber Cancer Institute

2006, Boston, MA

Fellowship

Pediatric Palliative Care

Boston Children's Hospital/Dana-Farber Cancer Institute

2006, Boston, MA

Fellowship

Health Services Research

Boston Children's Hospital

2007, Boston, MA

Certifications

  • American Board of Pediatrics (Hematology-Oncology)
  • American Board of Pediatrics (Hospice and Palliative Medicine)

Professional History

Christina Ullrich is PACT Clinical Director. She’s a PACT attending, and an Assistant Professor in Pediatrics at Harvard Medical School. She completed fellowships in Pediatric Hematology/Oncology and Pediatric Palliative Care at Boston Children’s Hospital/Dana-Farber Cancer Institute and is board certified in Hospice and Palliative Medicine and Pediatric Hematology/Oncology. Her research interests include symptom management in children with cancer, with a focus on fatigue. She is also currently investigating the palliative care needs of children who undergo hematopoietic stem cell transplantation.

Publications

  1. What do pediatric transplant physicians think about palliative care? Results from a national survey study. Bone Marrow Transplant. 2025 May 04. View Abstract

  2. Leading a Palliative Care Team Through Times of Growth And Change. J Palliat Med. 2024 Nov; 27(11):1439-1449. View Abstract

  3. Household material hardship and distress among parents of children with advanced cancer: A report from the PediQUEST Response trial. Cancer. 2024 Oct 15; 130(20):3540-3548. View Abstract

  4. What do patients think about palliative care? A national survey of hematopoietic stem cell transplant recipients. Blood Adv. 2023 05 23; 7(10):2032-2041. View Abstract

  5. Revisiting medical neglect concerns in children with life-threatening complex chronic conditions. Child Abuse Negl. 2023 07; 141:106220. View Abstract

  6. Concerns for Medical Neglect in Children with Complex or Serious Medical Conditions: What Pediatric Palliative Care Brings to the Table. J Palliat Med. 2023 04; 26(4):456-457. View Abstract

  7. Fatigue in Hematopoietic Cell Transplantation Survivors: Correlates, Care Team Communication, and Patient-Identified Mitigation Strategies. Transplant Cell Ther. 2023 03; 29(3):200.e1-200.e8. View Abstract

  8. An Automatic Pediatric Palliative Care Consultation for Children Supported on Extracorporeal Membrane Oxygenation: A Survey of Perceived Benefits and Barriers. J Palliat Med. 2022 06; 25(6):952-957. View Abstract

  9. "Good Grief": An Opportunity to Grow, Integrate, or Something Else? J Palliat Med. 2022 02; 25(2):178-179. View Abstract

  10. Health Care Providers' Perspectives on COVID-19 and Medical Neglect in Children with Life-Threatening Complex Chronic Conditions. J Child Adolesc Trauma. 2022 Mar; 15(1):193-199. View Abstract

  11. The Online Life Story Book: A randomized controlled trial on the effects of a digital reminiscence intervention for people with (very) mild dementia and their informal caregivers. PLoS One. 2021; 16(9):e0256251. View Abstract

  12. Are we undermining the value of palliative care through advanced cancer clinical trial consent language? Cancer. 2021 06 15; 127(12):1954-1956. View Abstract

  13. The Impact of Specialty Palliative Care in Pediatric Oncology: A Systematic Review. J Pain Symptom Manage. 2021 05; 61(5):1060-1079.e2. View Abstract

  14. Children at the Intersection of Pediatric Palliative Care and Child Maltreatment: A Vulnerable and Understudied Population. J Pain Symptom Manage. 2021 07; 62(1):91-97. View Abstract

  15. The Palliative Use of Intrathecal Baclofen in Niemann-Pick Disease Type C. Pediatrics. 2019 11; 144(5). View Abstract

  16. Models of Pediatric Palliative Oncology Outpatient Care-Benefits, Challenges, and Opportunities. J Oncol Pract. 2019 09; 15(9):476-487. View Abstract

  17. Patient- and Nurse-Controlled Analgesia: 22-Year Experience in a Pediatric Hospital. Hosp Pediatr. 2019 02; 9(2):129-133. View Abstract

  18. Self-reported fatigue in children with advanced cancer: Results of the PediQUEST study. Cancer. 2018 09 15; 124(18):3776-3783. View Abstract

  19. Rosalie Lightning: A Graphic Memoir. J Palliat Med. 2018 May; 21(5):730-731. View Abstract

  20. From the Child's Word to Clinical Intervention: Novel, New, and Innovative Approaches to Symptoms in Pediatric Palliative Care. Children (Basel). 2018 Mar 28; 5(4). View Abstract

  21. Engaging Patients in Setting a Patient-Centered Outcomes Research Agenda in Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2018 06; 24(6):1111-1118. View Abstract

  22. Strange Bedfellows No More: How Integrated Stem-Cell Transplantation and Palliative Care Programs Can Together Improve End-of-Life Care. J Oncol Pract. 2017 09; 13(9):569-577. View Abstract

  23. Three sides to a story: Child, parent, and nurse perspectives on the child's experience during hematopoietic stem cell transplantation. Cancer. 2017 Aug 15; 123(16):3159-3166. View Abstract

  24. Quality of Life in Children With Advanced Cancer: A Report From the PediQUEST Study. J Pain Symptom Manage. 2016 08; 52(2):243-53. View Abstract

  25. End-of-Life Care Patterns Associated with Pediatric Palliative Care among Children Who Underwent Hematopoietic Stem Cell Transplant. Biol Blood Marrow Transplant. 2016 06; 22(6):1049-1055. View Abstract

  26. Caring for Children Who Have Severe Neurological Impairment. J Palliat Med. 2015 Nov; 18(11):991. View Abstract

  27. Parent Outlook: How Parents View the Road Ahead as They Embark on Hematopoietic Stem Cell Transplantation for Their Child. Biol Blood Marrow Transplant. 2016 Jan; 22(1):104-11. View Abstract

  28. Symptoms and Distress in Children With Advanced Cancer: Prospective Patient-Reported Outcomes From the PediQUEST Study. J Clin Oncol. 2015 Jun 10; 33(17):1928-35. View Abstract

  29. Feasibility of Conducting a Palliative Care Randomized Controlled Trial in Children With Advanced Cancer: Assessment of the PediQUEST Study. J Pain Symptom Manage. 2015 Jun; 49(6):1059-69. View Abstract

  30. Putting pediatric palliative care in prime time. J Clin Oncol. 2014 Nov; 32(31_suppl):68. View Abstract

  31. Caring for children living with life-threatening illness: a growing relationship between pediatric hospital medicine and pediatric palliative care. Pediatr Clin North Am. 2014 Aug; 61(4):xxi-xxiii. View Abstract

  32. Pediatric hospital care for children with life-threatening illness and the role of palliative care. Pediatr Clin North Am. 2014 Aug; 61(4):719-33. View Abstract

  33. Improving the care of children with advanced cancer by using an electronic patient-reported feedback intervention: results from the PediQUEST randomized controlled trial. J Clin Oncol. 2014 Apr 10; 32(11):1119-26. View Abstract

  34. Pediatric palliative care research comes of age: what we stand to learn from children with life-threatening illness. J Palliat Med. 2013 Apr; 16(4):334-6. View Abstract

  35. Longitudinal Assessment of Symptom Distress in Children with Advanced Cancer: Report of the First 20 Weeks in the Pediatric Quality-of-Life Evaluation of Symptoms Technology (PediQUEST) Study (311-A). J Pain Symptom Manage. 2011 Jan; 41(1):187. View Abstract

  36. Routine Feedback of Patient-Reported Distress in Children With Advanced Cancer: Provider and Family Satisfaction With the Pediatric Quality of Life and Evaluation of Symptoms Technology (PediQUEST) System (311-B). J Pain Symptom Manage. 2011 Jan; 41(1):187-8. View Abstract

  37. Fatigue in children with cancer at the end of life. J Pain Symptom Manage. 2010 Oct; 40(4):483-94. View Abstract

  38. End-of-life experience of children undergoing stem cell transplantation for malignancy: parent and provider perspectives and patterns of care. Blood. 2010 May 13; 115(19):3879-85. View Abstract

  39. An economic analysis of anemia prevention during infancy. J Pediatr. 2009 Jan; 154(1):44-9. View Abstract

  40. An Economic Analysis of Anemia Prevention during Infancy. J. Peds. 2008; in press.

  41. Pain and Symptom Control in Pediatrics. Palliative Medicine (Walsh, Caraceni, Fainsinger, Foley, Glare, Goh, Lloyd-Williams, Radbruch). 2008.

  42. Assessment and management of fatigue and dyspnea in pediatric palliative care. Pediatr Clin North Am. 2007 Oct; 54(5):735-56, xi. View Abstract

  43. An Economic Analysis of Anemia Prevention During Infancy. Pediatric Research. 2007.

  44. Manual of Pediatric Therapeutics (Graef, Wolfsdorf, Greenes). 2007; 1-16.

  45. American Academy of Pediatrics Pedialink Hot Topics Educational Module: Iron Deficiency. 2007.

  46. Factors associated with fatigue in children with cancer at the end of life. J Clin Oncol. 2006 Jun 20; 24(18_suppl):8574. View Abstract

  47. Factors associated with fatigue in children with cancer at the end of life. Journal of Clinical Oncology. 2006; 24(18S):486S.

  48. Iron Deficiency in Infants and Toddlers. 2006.

  49. Diagnosis of Iron Deficiency in Children. 2006.

  50. Approaches to screening for iron deficiency in pediatrics: An update article. Italian J. Pediatrics. 2006; 32(5).

  51. Screening healthy infants for iron deficiency using reticulocyte hemoglobin content. JAMA. 2005 Aug 24; 294(8):924-30. View Abstract

  52. The importance of newborn screening in resident education. Pediatr Ann. 2003 Aug; 32(8):549-50. View Abstract

  53. Diet history as an adjunct to hemoglobin (Hb) and reticulocyte hemoglobin content (CHr) in screening for iron deficiency. Pediatric Research. 2003; 53(4):293A.

  54. Reticulocyte hemoglobin content (CHr) is better than hemoglobin in identifying iron deficiency. Pediatric Research. 2003; 53(4):293A.

  55. HIV-1 Tat induces microvascular endothelial apoptosis through caspase activation. J Immunol. 2001 Sep 01; 167(5):2766-71. View Abstract

  56. HIV-1 gp120- and gp160-induced apoptosis in cultured endothelial cells is mediated by caspases. Blood. 2000 Aug 15; 96(4):1438-42. View Abstract

  57. Posttranslational modifications of the 5'-AMP-activated protein kinase beta1 subunit. J Biol Chem. 1997 Sep 26; 272(39):24475-9. View Abstract

  58. Assignment of acetyl-CoA carboxylase-beta (ACACB) to human chromosome band 12q24.1 by in situ hybridization. Cytogenet Cell Genet. 1997; 77(3-4):176-7. View Abstract

  59. Acifluorfen Resistance in Arabidopsis thaliana. 1994.
BESbswy